Histogenics Corporation IPO Research Information

Histogenics Corporation IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Histogenics Corporation, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Histogenics Corporation	HSGX - NASDAQ	$13.00-$15.00	$11.00	$11.35	5.91 million	12/3/2014
Underwriter(s): Cowen & Co., Needham & Co., Canaccord Genuity
Co-Manager(s): BTIG
Industry: Health Care
Filing(s): Filed 2014-10-07 Terms Added 2014-11-14

Histogenics Corporation Quote & Chart - Click for current quote - HSGX

About Histogenics Corporation (adapted from Histogenics Corporation prospectus):
They are a regenerative medicine company focused on developing and commercializing products in the musculoskeletal segment of the marketplace.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "HSGX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.